|
Title
|
|
|
|
Investigation of biotransformation products of p-methoxymethylamphetamine and dihydromephedrone in wastewater by high-resolution mass spectrometry
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| There is a paucity of information on biotransformation and stability of new psychoactive substances (NPS) in wastewater. Moreover, the fate of NPS and their transformation products (TPs) in wastewater treatment plants is not well understood. In this study, batch reactors seeded with activated sludge were set up to evaluate biotic, abiotic, and sorption losses of p-methoxymethylamphetamine (PMMA) and dihydromephedrone (DHM) and identify TPs formed during these processes. Detection and identification of all compounds was performed with target and suspect screening approaches using liquid chromatography quadrupole-time-of-flight mass spectrometry. Influent and effluent 24 h composite wastewater samples were collected from Athens from 2014 to 2020. High elimination rates were found for PMMA (80%) and DHM (97%) after a seven-day experiment and degradation appeared to be related to biological activity in the active bioreactor. Ten TPs were identified and the main reactions were O- and N-demethylation, oxidation, and hydroxylation. Some TPs were reported for the first time and some were confirmed by reference standards. Identification of some TPs was enhanced by the use of an in-house retention time prediction model. Mephedrone and some of its previously reported human metabolites were formed from DHM incubation. Retrospective analysis showed that PMMA was the most frequently detected compound. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Metabolites
| |
|
Publication
|
|
|
|
2021
| |
|
ISSN
|
|
|
|
2218-1989
| |
|
DOI
|
|
|
|
10.3390/METABO11020066
| |
|
Volume/pages
|
|
|
|
11
:2
(2021)
, 12 p.
| |
|
Article Reference
|
|
|
|
66
| |
|
ISI
|
|
|
|
000622762100001
| |
|
Pubmed ID
|
|
|
|
33503865
| |
|
Medium
|
|
|
|
E-only publicatie
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|